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Salen-manganese complexes exhibit powerful superoxide dismutase and catalase activity, with pharmacologic
efﬁcacy in several oxidative-stress-associated disease models. Ultraviolet (UV) B not only induces direct DNA
damage, but also generates oxidative stress. EUK-134, a salen-manganese complex, might therefore confer a direct
protection against UVB-induced oxidative stress and consequently alleviate UVB-damage-induced signal
transduction. We investigated the effect of EUK-134 on the UVB-induced accumulation and stabilization of the
p53 protein. p53 plays a central role in the UVB response, both as sensor of UVB damage and as a mediator of a
protective response. Cells treated with EUK-134 before UVB irradiation showed a signiﬁcantly lower accumulation
of the p53 protein in a concentration-dependent fashion. Furthermore, EUK-134 severely reduced N-terminal
phosphorylation of p53. The extracellular signal-regulated kinase ERK and the stress-activated kinases JNK and
p38 have been implicated in the UVB-induced N-terminal phosphorylation and accumulation of p53. Pre-treatment
with EUK-134 inhibited the UVB-induced activation of these mitogen-activated protein kinase (MAPK) pathways. We
hypothesize that EUK-134, by direct protection of the membrane from UVB-induced oxidative damage, reduces
oxidative stress induced MAPK signaling and consequently lowers the level of p53 induction. The protection
conferred by EUK-134 resulted in a signiﬁcant increase in cell survival following UVB irradiation.
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Exposure of human skin to ultraviolet (UV) radiation has
well-known acute and chronic effects. The acute effects
include erythema, tanning, and immune suppression. Long-
term adverse effects of UV exposure are photoaging and
photocarcinogenesis (Gilchrest et al, 1996; Taylor and
Sober, 1996; Clydesdale et al, 2001). Not only UV-induced
direct DNA damage, but also UV-induced reactive oxygen
species (ROS) are involved in these processes (de Gruijl
et al, 2001; Scharffetter-Kochanek et al, 1997). ROS can
cause genetic damage, both to mitochondrial and to
nuclear DNA. ROS are also involved in photodamage of
the dermal connective tissue, characteristic for photoaging,
both through direct damage to connective tissue cells and
proteins and through the induction of proteolytic pathways
(Ma et al, 2001).
In a healthy epidermis, a keratinocyte protects itself from
the deleterious effects of UVB damage by undergoing a
typical UVB response. The cell undergoes a cell-cycle arrest
and repairs its DNA at low UVB doses, whereas high UVB
doses bring about a last escape mechanism: the induction
of programmed cell death or apoptosis. p53 plays a central
role in this response both as a sensor of UVB damage and
as an initiator of a program of expression of genes involved
in growth arrest, repair, or apoptosis. DNA damage elicited
by UVB is thought to an important trigger for p53
accumulation and transcriptional activation (Decraene et al,
2001).
Nevertheless, a growing amount of data suggest that the
complex cellular response induced by UVB (290–320 nm)
not only involves events triggered by DNA damage, but also
depends on cytosolic signaling pathways originating at the
plasma membrane (Assefa et al, 1997; Kulms et al, 2002).
Although UVA is generally regarded as the prime source for
ROS in sunlight-induced damage, UVB also produces a
substantial amount of ROS through interaction with en-
dogenous photosensitizers (Peus et al, 1999a), leading to
the depletion of enzymatic and nonenzymatic antioxidant
systems (Sander et al, 2002). UVB-generated ROS damage
the plasma membrane, resulting in the ligand-independent
clustering of membrane receptors. The consequent activa-
Abbreviations: AAPH, 2,20-azobis(2-amidinopropane)dihydrochlor-
ide; ERK, extracellular signal-regulated kinase; JNK/SAPK, c-Jun
N-terminal kinase/stress-activated protein kinase; MAPK, mitogen-
activated protein kinase; ROS, reactive oxygen species; SOD,
superoxide dismutase; UV, ultraviolet.
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tion of receptors in the absence of ligand binding initiates
specific signaling cascades, particularly the stress-induced
mitogen-activated protein kinase (MAPK), within minutes
of UVB exposure (Rosette and Karin, 1996; Peus et al,
1999b).
A reduction in the level of UVB-generated oxidative
damage is therefore bound to have an impact on the major
UVB-responsive pathways. We therefore investigated the
impact of a salen-manganese complex, EUK-134, on
the UVB response of primary human keratinocytes. The
synthetic salen-manganese complexes, a class of stable
low-molecular-weight compounds that contain tightly
bound manganese, exhibit powerful superoxide dismutase
(SOD) and catalase activity, targeting and destroying both
superoxide and hydrogen peroxide, respectively (Baker
et al, 1998; Baudry et al, 1993; Doctrow et al, 1997). These
SOD/catalase mimetics have shown efficacy in a variety of
oxidative stress paradigms, including in vivo models for
stroke (Baker et al, 1998), Parkinson’s disease (Melov et al,
2001), autoimmune disease (Malfroy et al, 1997), and
excitotoxic neuronal death (Rong et al, 1999). Furthermore,
an augmentation of the natural antioxidant system with
synthetic salen manganese complexes was shown to
increase life span in certain animal models (Melov et al,
2000) and to reverse age-related learning deficits in mice
(Melov et al, 2001; Liu et al, 2003). Studies have shown that
activation of MAPK signal transduction pathways in
response to UVB is presumably triggered by ROS-mediated
membrane damage (Peus et al, 1999a; Rosette and Karin,
1996).
We show that a pre-treatment with EUK-134 inhibits the
UVB-induced activation of MAPK signal transduction path-
ways in human keratinocytes. This results in a lower
accumulation of p53, a protein central in the response to
UVB damage. In turn, this leads to a significant increase in
cell survival. Our results indicate that low concentrations of
EUK-134 can effectively protect cells against oxidative
damage by UVB. Our results also show that in addition to
direct damage, ROS-dependent events are involved in the
accumulation of p53 upon UVB exposure. These data shed
new light on the importance of ROS-mediated signal
transduction in the UVB-response of human skin. They
point out a potential use for salen-manganese complexes
as protective agents against the ROS-dependent deleter-
ious effects of chronic UV exposure: photoaging, and
photocarcinogenesis.
Results
EUK-134 protects primary human keratinocytes against
oxidative stress The structure of the salen-manganese
complex EUK-134 is shown in Fig 1. EUK-134 is an analog
of EUK-8 with increased catalase activity and equivalent
SOD activity (Doctrow et al, 2002).
We first investigated whether EUK-134 retains its
catalase- and SOD-like activity under UVB irradiation.
EUK-134 solutions were irradiated with doses up to 300
mJ per cm2 UVB (Fig 2A) and subsequently subjected to
analysis. The catalase-like activity, the ability to neutralize
H2O2, was assayed by monitoring the rate of conversion of
hydrogen peroxide to oxygen as a decrease in absorbance
at 240 nm, as originally described by Beers and Sober
(1952). Catalase activity of sham-irradiated EUK-134,
extrapolated from a standard curve of bovine liver catalase,
was calculated to be 26 U per mg. The SOD-like activity of
EUK-134, the ability to neutralize O2
–, was determined by its
ability to compete with luminol for superoxide anion, leading
to a decrease in the chemiluminescent signal, as modified
from Kimura and Nakano (1988). Superoxide was generated
in situ through the hypoxanthine/xanthine oxidase system.
SOD-like activity of sham-irradiated EUK-134, extrapolated
from a standard curve of bovine erythrocyte SOD, was
estimated to be 0.33 U per mg. Both the SOD-like and the
catalase-like activity of EUK-134 proved to be stable under
increasing UVB doses (Fig 2A).
Oxidative damage to membranes is thought to be the
main cause for the activation of several UVB-induced
signaling cascades (Rosette and Karin, 1996; Peus et al,
1999b). We therefore sought whether the antioxidative
properties of EUK-134 could confer protection against the
oxidation of lipids. The ability of EUK-134 to protect linoleic
acid against ROS-induced lipid peroxidation was tested
using the radical initiator AAPH (Fig 2B). Thermal decom-
position (371C) of the azo compound AAPH generates free
radicals that rapidly react with oxygen to give peroxyl
radicals. The peroxyl radicals abstract hydrogen atoms
from the linoleic acid to give lipid radicals. These lipid
radicals then induce a sequence of propagation reactions to
give lipid hydroperoxides. The progress of lipid peroxidation
was followed by the rate of appearance of conjugated
dienes at 234 nm as a function of time. EUK-134 strongly
reduced the propagation rate of the peroxidation reaction,
resulting in a concentration-dependent decrease of the
slope (Fig 2B). The concentration causing 50% inhibition
(IC50) was estimated to be approximately 0.8 mM EUK-134
under the test conditions described.
We next investigated whether EUK-134 could effectively
protect cultured human keratinocytes against oxidative
stress. To demonstrate a protective effect of EUK-134
against oxidative-stress-induced cytotoxicity, we performed
a neutral red viability assay (Fautz et al, 1991). Neutral red is
readily incorporated into the lysosomes of living cells. The
uptake of the neutral red dye, monitored by an increase in
absorbance at 540 nm, is therefore a direct indication for
Figure1
Structures of the salen-manganese complexes EUK-8 and EUK-
134. The ring substituents (R) of EUK-8 and EUK-134 differ as shown
(with permission from Eukarion, Inc.).
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the amount of viable cells. A 24-h pre-treatment with EUK-
134 (12.5–50 mM) significantly reduced hydrogen peroxide
induced cytotoxicity (150–300 mM H2O2; Fig 2C). Likewise, a
24-h pre-treatment with 25 to 50 mM EUK-134 significantly
reduced xanthine oxidase/xanthine-induced cytotoxicity
(0.5–2 U/mL xanthine oxidase, Fig 2C). Xanthine oxidase
catalyzes the oxidation of xanthine, present in cell culture
medium, leading to the production of superoxide (Kimura
and Nakano, 1988).
EUK-134 inhibits p53 N-terminal phosphorylation and
p53 accumulation in UVB-irradiated primary human
keratinocytes UVB causes both direct DNA damage and
oxidative stress. Both induce phosphorylation, stabilization,
and consequent accumulation of the p53 protein. To further
demonstrate the antioxidative capacity of EUK-134, we
exposed cells for 10 min to increasing concentrations of
hydrogen peroxide (0.01–0.2 mM). Hydrogen peroxide
induced a concentration-dependent accumulation of the
p53 protein 6 h after treatment (Fig 3a). A 24-h pre-
treatment with 50 mM EUK-134 led to a near complete
inhibition of this oxidative stress-induced p53 accumulation.
Next, we investigated whether a pre-treatment with EUK-
134 was also able to prevent or reduce p53 accumulation
following UVB irradiation. Indeed, a 24-h pre-treatment with
increasing doses (0.5–50 mM) of EUK-134 led to a
concentration-dependent decrease of p53 accumulation 6
h after irradiation with 12 mJ per cm2 UVB (Fig 3b). This
dramatic decline of UVB-induced p53 accumulation in EUK-
134-pre-treated cells (50 mM, 24-h pre-incubation) was
consistent across a wide range of UVB doses (Fig 3c). Next,
the phosphorylation of two serine sites was monitored by
western blotting. A 24-h pre-incubation with 50 mM EUK-
134 completely inhibited the UVB-induced (32 mJ/cm2)
phosphorylation of serine 46 (Fig 3d). In EUK-134-treated
cells a diminished accumulation of the p53 protein following
UVB-damage also strongly correlated with a decreased
phosphorylation of the serine 15 phosphorylation site (Fig 3d).
EUK-134 pre-treatment attenuates UVB-induced MAPK
activation in primary human keratinocytes One of the
predominant UVB-responsive signaling pathways is the
MAPK pathway, which has three distinct components:
the ERK pathway, the stress-activated JNK pathway, and
the stress-activated p38 pathway. MAPK play an important
role in p53 stabilization and accumulation by phosphorylat-
ing the N-terminus of the p53 protein at several serine and
threonine sites (Ser15, Ser20, Ser33, Ser46, Thr81) in
response to oxidative membrane damage. The phospho-
p44/42 MAPK antibody recognizes dually phosphorylated
Figure2
EUK-134 pre-treatment protects ker-
atinocytes against oxidative stress.
(A) EUK-134 solutions were either sham
irradiated or exposed to increasing UVB
doses. Following UVB-irradiation, the
catalase-like (U/mg) and the SOD-like
activity (U/mg) of the solution was
calculated as described under Materials
and Methods. (B) The ability of EUK-134
to prevent lipid peroxidation in vitro was
tested using AAPH as a radical initiator
and linoleic acid as a substrate, as
described under Materials and Meth-
ods. The concentration of EUK-134
varied from 0.25 to 5 mM as indicated.
Ethanol represents the control without
EUK-134. (C) Cells were pre-treated for
24 h with increasing EUK-134 doses
(12.5–50 mM as indicated) and subse-
quently exposed to increasing concen-
trations of either hydrogen peroxide
(100–400 mM) or xanthine oxidase
(0.125–2 U/mL). The uptake of neutral
red dye was monitored 18 h after H2O2
or xanthine oxidase exposure, as de-
scribed under Materials and Methods
(mean  SD). po0.05 (Student’s t
test). The above data are representative
of three independent experiments.
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ERK1 (p44) as well as dually phosphorylated ERK2 (p42)
MAPK. The UVB-dependent increase in both ERK1 and
ERK2 activation was completely inhibited by a 24-h pre-
treatment with 50 mM EUK-134 (Fig 4a). Basal activation of
the ERK pathway, owing to the presence of epidermal
growth factor, was unaffected by EUK-134 pre-treatment.
The UVB-induced activation of JNK protein kinases was
largely inhibited in cells pre-treated with 50 mM EUK-134
(Fig 4b). The antibody recognizes two alternative splicing
variants (a 46- and a 54-kDa variant) of both the JNK1 and
the JNK2 protein kinase (Gupta et al, 1996). The UVB-
induced activation of SEK1/MKK4, a MAPK that phosphor-
ylates and activates JNK1 and JNK2, was also severely
inhibited by a 24-h pre-treatment with 50 mM EUK-134 (Fig 4b).
The activation of the p38 MAPK pathway could only be
observed when cells were irradiated with higher UVB doses
(32–64 mJ/cm2; Fig 4c). EUK-134 pre-treatment led to a
near complete inhibition of p38 MAPK phosphorylation and
activation. Correspondingly, the activation of both MKK3
and MKK6, two closely related protein kinases that
phosphorylate p38 MAP kinase following UVB damage
(32–64 mJ/cm2), was almost completely inhibited (Fig 4c).
Inhibition of the p38 MAPK pathway decreases p53
N-terminal phosphorylation and accumulation following
UVB-damage By use of a pharmacologic inhibitor, we
wanted to investigate whether an inhibition of the p38
MAPK pathway had similar effects on the UVB-induced
N-terminal phosphorylation and accumulation of the p53
protein. By binding to the ATP pocket of p38 MAPK, the
pyridinyl imidazole inhibitor PD169316 potently inhibits p38
MAPK activation (Young et al, 1997). Inhibition of the p38
Figure 3
EUK-134 pre-treatment reduces p53 N-terminal
phosphorylation and p53 accumulation following
UVB irradiation. p53 protein levels and the p53
phosphorylation status following oxidative stress or
UVB damage were determined by western blotting as
described under Materials and Methods. (A) Where
indicated, primary human keratinocytes were pre-
treated for 24 h with 50 mM EUK-134. Cells were then
exposed for 10 min to increasing concentrations of
H2O2 (0.01–0.2 mM). The cell lysate was collected 6 h
later and analyzed for total p53 level. (B) Primary
human keratinocytes were pre-treated for 24 h with
increasing concentrations of EUK-134, as indicated.
Cells were scraped 6 h after sham irradiation or
irradiation with 12 mJ per cm2 UVB and analyzed for
total p53 levels. (C) Dose response of p53 accumula-
tion, 6 h after UVB irradiation. Where indicated, cells
were pre-treated for 24 h with 50 mM EUK-134. Cells
were irradiated with increasing UVB doses, as
indicated, and evaluated for total p53 levels. (D) Time
course analysis of the phosphorylation status of the
p53 protein following irradiation with 32 mJ per cm2
UVB. Cells, pre-treated with 50 mM EUK-134 where
indicated, were scraped at the appropriate time point
and analyzed for total p53 levels, p53 phosphorylation
at Ser46, and p53 phosphorylation at Ser15.
Figure 4
EUK-134 pre-treatment prevents the UVB-
induced activation of three major MAPK
pathways. Where indicated, cells were treated
with 50 mM EUK-134 24 h before UVB irradia-
tion. Cell lysates were collected 15 min after
irradiation with the indicated UVB dose. Pro-
teins were separated by Western blotting as
described under Materials and Methods. Mem-
branes were probed with phosphospecific
antibodies. (A) ERK1 and ERK2 phosphoryla-
tion status (ERK-MAPK pathway). (B) MKK4,
JNK1, and JNK2 phosphorylation status (JNK/
SAPK pathway). (C) MKK3, MKK6, and p38
MAPK phosphorylation status (p38 MAPK
pathway).
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MAPK pathway by a 30-min pre-treatment with increasing
concentrations of PD169316 (1–10 mM) resulted in a strong
inhibition of the UVB-induced p53 phosphorylation at serine
15 and serine 46 (Fig 5). Consequently, the inhibition of the
p38 MAPK pathway by a 30-min PD169316 pre-treatment
(1–10 mM) resulted in a corresponding decrease of p53
accumulation following irradiation with 32 mJ per cm2 UVB,
similar to a EUK-134 pre-treatment.
EUK-134 pre-treatment increases cell survival after UVB
irradiation Next, we wanted to investigate how pre-
treatment with EUK-134 influenced the fate of a cell
following UVB irradiation. The amount of viable cells was
determined by a trypan blue exclusion assay. Cells were
treated with 5 or 50 mM EUK-134 24 h before UVB
irradiation. UVB induced a concentration-dependent loss
of cell viability in keratinocytes (Fig 6). EUK-134 treatments
were found to increase cell viability following UVB irradiation
in primary human keratinocytes. A 24-h pre-treatment with
either 5 or 50 mM EUK-134 significantly reduced cell death
with 16 and 25%, respectively (po0.01) following irradiation
with 24 mJ per cm2 UVB. A pre-treatment with 50 mM EUK-
134 also significantly reduced cell death following UVB
irradiation with 16 mJ per cm2 with 7% (po0.01).
Discussion
The SOD and catalase mimic EUK-134, stable under UVB
irradiation, was found to potently protect cultured human
keratinocytes against oxidative-stress-induced damage.
Because UVB-generated oxidative stress is known to be
an important trigger for UVB-induced cytosolic signaling
(Peus et al, 1999a; Peus et al, 1999b), we wanted to
investigate whether a supplementation of primary human
keratinocytes with the antioxidant EUK-134 could conse-
quently affect the UVB response of these keratinocytes.
Our results show that EUK-134 inhibits the UVB-induced
activation of three members of the MAPK signal transduc-
tion pathway: ERK, JNK, and p38. Inhibition of these UVB-
activated pathways by EUK-134 was accompanied by a
prevention of UVB-induced p53 N-terminal phosphorylation
at Ser15 and Ser46 and subsequently p53 accumulation. In
turn this led to a small but significant increase in cell survival
upon UVB irradiation. These results underline the impor-
tance of oxidative membrane damage as an initiator of
MAPK signal transduction and p53 accumulation following
UVB irradiation. Furthermore, EUK-134 strongly reduced
oxidative-stress-elicited damage response pathways fol-
lowing UVB-irradiation. The antioxidative properties of this
molecule could thus prove useful against both short- and
long-term deleterious effects of UVB irradiation.
The salen-manganese complexes have proven their
efficacy as oxidative stress scavengers in a number of
experimental models (Malfroy et al, 1997; Baker et al, 1998;
Rong et al, 1999; Melov et al, 2000). We have shown that the
antioxidative properties of EUK-134, member of the salen-
manganese complex family, are preserved under UVB
irradiation and potently protect cultured keratinocytes
against oxidative damage. Our data further suggest that
EUK-134 effectively protects against oxidative membrane
damage. Indeed EUK-134 was found to prevent lipid
peroxidation elicited by a radical initiator and linoleic acid
as a substrate. Oxidative membrane damage is thought to
be the initiator of several UVB-responsive signaling path-
ways that originate at the plasma membrane (Peus et al,
1999b; Rosette and Karin, 1996). A supplementation with
EUK-134 before UVB irradiation might replenish the cell’s
capacity to neutralize oxidative stress, because UVB
irradiation depletes the endogenous antioxidant levels in
human skin (Sander et al, 2002).
A major UVB-responsive pathway is the MAPK pathway.
The MAPK pathway consists of three components in
mammals, the ERK pathway, the JNK/SAPK pathway, and
the p38 kinase pathway. Stress-induced MAPK activation is
the result of ROS-mediated, ligand-independent clustering
of membrane receptors (Rosette and Karin, 1996). If a
pre-treatment with EUK-134 is able to protect the cell
membrane against UVB damage in vivo, this would
consequently result in a severely decreased activation of
the MAPK pathways. Indeed, a pre-treatment with EUK-134
strongly downregulated the UVB-induced activation of all
three MAPK pathways (Fig 4). Furthermore, the ERK
pathway is primarily activated in response to growth factors
and is only modestly activated by UV irradiation (Assefa
et al, 1997). The presence of epidermal growth factor in the
keratinocyte medium leads to a sustained basal activation
of the ERK pathway (Fig 4). Although EUK-134 pre-
treatment did not affect the basal growth factor-dependent
activation of this pathway, it completely inhibited UVB-
damage-induced activation of this pathway. EUK-134 thus
only inhibits UVB-damage-induced MAPK signaling, not
mitogen-induced MAPK signaling. These data reinforce our
hypothesis and suggest that EUK-134 might also effectively
protect the cellular membrane against UVB-induced oxida-
tive stress in vivo.
Figure 5
Inhibition of the p38 MAPK pathway reduces p53 N-terminal phosphorylation and p53 accumulation following UVB irradiation. Half an hour
before UVB irradiation, cells were pre-treated with increasing concentrations of the p38 MAPK inhibitor PD169316 (1–10 mM). Cells were then
irradiated with 32 mJ per cm2 UVB and scraped at the indicated time point. p53 phosphorylation at serine 46, p53 phosphorylation at serine 15, and
total p53 level was determined by western blotting as described under Materials and Methods.
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The p53 protein quickly accumulates following various
forms of environmental stresses, including DNA-damaging
agents, decreased oxygen, heat shock, and redox stress
(Giaccia and Kastan, 1998). UVB induces both direct DNA
damage and oxidative stress (Assefa et al, 1997; Kulms
et al, 2002). In our experimental setup p53 accumulation
following oxidative stress (in the form of exogenously
applied H2O2) was shown to be nearly completely pre-
vented by a pre-treatment with the antioxidant EUK-134. In
agreement with this observation, p53 accumulation upon
UVB exposure was severely reduced by an EUK-134 pre-
treatment. This again indicates an important role for UVB-
elicited oxidative stress in the stress signaling to and
accumulation of p53 following UVB damage.
We further investigated the mechanisms involved in this
reduction of p53 accumulation. A severe reduction in the
amount of oxidative stress and thus membrane damage
following UVB irradiation can be expected to lower p53
accumulation through the suppression of MAPK activation.
Indeed, MAPK are activated by ROS induced ligand-
independent clustering of membrane receptors and these
MAPK can phosphorylate several N-terminal phosphoryla-
tion sites on the p53 protein. Phosphorylation of these sites
plays an important role in p53 stabilization, subsequent
accumulation, and transcriptional activation (Oda et al,
2000; Buschmann et al, 2001). Among the N-terminal
phosphorylation sites of p53 inducible by MAPK are serine
15 and serine 46. Serine 15 has been shown to be a
targeted by ERK and the p38 MAPK. Phosphorylation of
serine 15 results in a disruption of the p53-MDM2 complex,
a key element in the stabilization and transcriptional
activation following UV-damage (She et al, 2000). Likewise,
serine 46 phosphorylation is p38 MAPK dependent and also
results in increased stabilization and transcriptional activa-
tion following UV damage (Bulavin et al, 1999). p53
accumulation following UVB damage was strongly reduced
in EUK-134-pre-treated cells over a wide range of UVB
doses (8–64 mJ/cm2). This reduction in p53 accumulation
was associated with a strong reduction of serine 15
phosphorylation and an almost complete inhibition of serine
46 phosphorylation. To investigate the importance of p38
MAPK activation in the stabilization and accumulation of
p53 following UVB damage, we treated cells with an
inhibitor of the p38 MAPK before UVB irradiation. A pre-
treatment with 10 mM PD169316 strongly reduced the
accumulation of p53 following UVB irradiation. Similarly to
the effect of EUK-134, the reduction in p53 accumulation
was associated with a strong reduction of both serine 15
phosphorylation and serine 46 phosphorylation.
These data again confirm the hypothesis that the cellular
response to UVB irradiation is not only governed by nuclear
events triggered by direct DNA damage. On the contrary,
cytosolic signaling pathways induced by membrane damage
also play an important role in the UVB response of human
keratinocytes. This is further demonstrated by the fact that a
pre-treatment with EUK-134 slightly but significantly reduced
cell death following irradiation with higher UVB doses.
The downstream targets of p53 determine the fate of the
cell, either cell-cycle arrest or apoptosis, depending on the
amount of damage induced (Decraene et al, 2001). This
response effectively prevents the proliferation of cells contain-
ing damaged DNA and is vital for cellular homeostasis. p53 is
therefore often called ‘‘the guardian of the genome.’’ Never-
theless, p53 induction seems to act as a double-edged
sword, because p53 plays a role in several theories of human
aging: involving DNA damage, telomere shortening, and also
oxidative stress (Sharpless and DePinho, 2002). Pharmaco-
logic targetting of p53 itself is unwanted, because the
resulting inhibition of p53 function might be complicated by
increased tumorigenesis. Clearly, the ultimate beneficial
action of a product on cells is the reduction of stress itself
(be it DNA damage, direct or indirect, or oxidative damage).
EUK-134 appears to be an efficient product in this respect,
because it addresses at least one part of this spectrum, the
inhibition of oxidative stress.
UVB-generated oxidative stress contributes to its
chronic deleterious effects, for example, photoaging and
photocarcinogenesis. Increased oxidative stress may lead
to increased mitochondrial and nuclear DNA damage,
subsequent mutation, and in the long run cancer. UVB-
induced oxidative stress is also involved in connective
tissue degradation, characteristic of dermal photodamage
and signature of photoaging. Sander and colleagues (2002)
have recently shown that the endogenous SOD and
catalase enzyme levels in the epidermis are depleted both
by chronic and by acute UV exposures and that photoaging
is associated with protein oxidation in human skin in vivo.
By replenishing the cell’s antioxidant defense, EUK-134
may prove to be very efficient in the fight against both the
short and the long-term (photoaging and photocarcinogen-
esis) deleterious effects of UVB irradiation on skin.
Materials and Methods
Cell culture Primary human keratinocytes were isolated and
pooled from foreskins of five different donors (less than 6 y) as
Figure 6
Protection against oxidative damage with EUK-134 increases cell
survival after UVB irradiation. Cells either were left untreated or were
treated with 5 or 50 mM EUK-134 24 h before UVB irradiation. Twenty-
four hours after UVB irradiation the percentage of UVB-induced cell
death was evaluated by a trypan blue exclusion assay as described
under Materials and Methods. Data are expressed as percentages
trypan blue exclusion (%TBE). One representative of two independent
experiments is shown (mean  SEM., n¼ 3). po0.01 (Student’s t test).
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described (Gilchrest, 1983). The procedure has been approved by
the ethical committee of the University of Leuven. Keratinocytes
were grown in serum-free medium (Keratinocyte-SFM, Invitrogen,
Merelbeke, Belgium) supplemented with bovine pituitary extract
(50 mg/mL) and human recombinant epidermal growth factor (5 ng/
mL). Third- to fifth-passage cells were used in experiments.
Antibodies and reagents Phospho-p44/42 MAP kinase (Thr202/
Tyr204, recognizes dually phosphorylated extracellular signal-
regulated kinase (ERK) 1 and ERK2), phospho-stress-activated
protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) (Thr183/
Tyr185, recognizes dually phosphorylated JNK1 and JNK2 iso-
forms), phospho-MKK3/6 (Ser189/207), phospho-SEK1/MKK4
(Thr261), phospho-p53 (Ser46), phospho-p38 MAP kinase
(Thr180/Tyr182), and p38 MAP kinase antibodies were purchased
from Cell Signaling (Beverly, MA). Anti-human p53 (clone DO-1)
antibody was purchased from PharMingen (BD Biosciences,
Erembodegem, Belgium). EUK-134 was purchased from Eukarion
Inc. (Bedford, MA). Hydrogen peroxide and xanthine oxidase were
purchased from Sigma-Aldrich (Bornem, Belgium).
UVB irradiation Before UVB irradiation cells were washed twice
with phosphate-buffered saline, irradiated through a thin film of
phosphate-buffered saline, and then refed with their own medium.
Cells were exposed through the cover of the dish, which filters out
residual UVC (Brown et al, 2001). The UVB source was a parallel
bank of three Philips TL 20W12 tubes with a peak output of 310 nm.
Output was measured through the cover of a tissue culture dish
with an IL700 radiometer (International light, Newburyport, MA).
Western blotting At the indicated time points, cells were scraped
in lysis buffer (25 mM HEPES, 0.3 mM NaCl, 1.5 mM MgCl2, 20 mM
b-glycerolphosphate, 2 mM ethylenediaminetetraacetic acid, 2 mM
ethylene glycol-bis(b-amino ethyl ether), pH 7.5) containing 1%
Triton, 10% glycerol, 1 mM Na3VO4, 0.5 mM dithiothreitol, 10 mg
per mL leupeptin, 10 mg per mL aprotinin, and 10 mg per mL
antipain. Extracts were incubated on ice and spun down at
21,000 g for 20 min. Protein concentration was determined using
the bicinchoninic acid protein assay reagent (Pierce Chemical
Company, Rockford, IL). A quantity of 50 to 80 mg of total protein
extract was separated by a 10% SDS-PAGE, followed by wet
electrotransfer onto Hybond-C Super membrane (Amersham
Pharmacia, Roosendaal, Netherlands). Equal loading of proteins
was verified using Ponceau-S in coloring (Klein et al, 1995).
Membranes were blocked for 1 h at room temperature in Tris-
buffered saline containing 0.1% Tween and 5% nonfat dry milk.
The membrane was incubated overnight at 41C with the primary
antibody, washed, and incubated for 1 h at room temperature with
the peroxidase-conjugated secondary antibody. Protein bands
were visualized using enhanced chemiluminescence as described
by the supplier (Amersham Pharmacia, Roosendaal, Netherlands).
Quantiﬁcation of the Catalase-like and SOD-like activity of
EUK-134 The catalase-like activity of EUK-134 was assayed by
monitoring the rate of conversion of hydrogen peroxide to oxygen
as a decrease in absorbance at 240 nm, as originally described by
Beers and Sober (1952). EUK-134 solutions (6 mg/mL in 50 mM
phosphate buffer, pH 7.0) were incubated on ice and exposed to
UVB irradiation. Following UVB irradiation, an equal volume of
H2O2 (Acros, Geel, Belgium; 34 mM in phosphate buffer) was
added. The decrease in UV absorbance at 240 nm was monitored
over a period of 2 min. Catalase-like activity (U/mg) was
extrapolated from a standard curve of different concentrations of
catalase (from bovine liver).
SOD-like activity of EUK-134 was determined as modified from
Kimura and Nakano (1988). The protocol is based on the ability of
EUK-134 to compete with luminol for the superoxide anion,
produced in situ using a hypoxanthine/xanthine oxidase system
and resulting in a decrease in chemiluminescent signal. Briefly,
EUK-134 solutions (120 mg/mL in 50 mM phosphate buffer, pH 7.0)
were incubated on ice and exposed to UVB. Following UVB
irradiation, 30 mL of EUK-134 solution was transferred to an equal
volume of xanthine oxidase (0.1 U/mL). Fifteen microliters of
luminol (0.5 mM) and 75 mL of hypoxanthine (0.735 mM) were
added and the chemiluminescence intensity was measured for 30
s. SOD-like activity (U/mg) was extrapolated from a standard curve
with different concentrations of SOD (from bovine erythrocytes). All
reagents were purchased from Sigma, unless stated otherwise.
Linoleic acid peroxidation assay The antioxidant activity of
EUK-134 was expressed as the ability to inhibit linoleic acid
peroxidation in vitro according to Liegeois et al (2000). Briefly,
oxidation of 16 mM linoleic acid in aqueous dispersions (in borate
buffer, pH 9, 0.5% Tween 20, 25 mM KOH, with or without EUK-
134) was initiated by addition of 4 mM of the radical initiator 2,20-
azobis(2-amidinopropane)dihydrochloride (AAPH) (Aldrich Chemi-
cal Company, Milwaukee, WI). The progress of lipid peroxidation at
371C in the presence of EUK-134 was continuously monitored by
spectrophotometric reading of the rate of appearance of con-
jugated dienes at 234 nm as a function of time.
Neutral red viability assay Primary human keratinocytes were
grown in 96-well plates to approximately 75% confluency. A pre-
treatment of EUK-134 at 12.5, 25, and 50 mM was carried out. Cells
were then exposed to increasing concentrations of H2O2 (100–400
mM) or xanthine oxidase (0.5–2 U/mL). Following an 18-h
incubation, 50 mg per mL neutral red dye (Aldrich Chemical
Company) was added to the medium. Three hours later, cells were
fixed in 1% formaldehyde-1% calcium chloride, rinsed three times
with phosphate-buffered saline, and lyzed with 1% acetic acid-
50% ethanol for 30 min. Absorbance at 540 nm was measured by
spectrophotometry.
Trypan blue exclusion assay Primary human keratinocytes were
plated in 60-mm cell culture dishes and grown to 75% confluency.
The keratinocytes were pre-incubated with EUK-134 at 0, 5, and
50 mM for a 24-h period before UVB irradiation at 8, 16, and 24 mJ
per cm2. Cells were harvested 24 h after UVB irradiation by
trypsinization and centrifugation. Cell viability was determined by
the trypan blue exclusion assay (Kaltenbach et al, 1958). Briefly,
pelleted cells where stained with 0.4% trypan blue (Aldrich
Chemical Company, Milwaukee, WI), followed by examination with
a hemacytometer under an inverted microscope. Cells that
excluded the dye were considered viable and the data are
expressed as the percentage of trypan blue exclusion.
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